Background Inappropriate doses of direct oral anticoagulants (DOACs) are often prescribed.
This study evaluated the prevalence, outcomes, and predictors of the prescription of …

Direct Oral Anticoagulants (DOACs) require dose adjustment based on specific patient
characteristics, making them prone to incorrect dosing. The current study aimed to evaluate …

Background The appropriateness of direct oral anticoagulant (DOAC) dosing has been the
issue in the real-world setting, and inappropriately lower DOAC dose may not be as effective …

Aims Since the introduction of direct oral anticoagulant (DOAC) for atrial fibrillation (AF)
therapy, inappropriate and/or underdosing of these drugs has been a major clinical …

Background: Direct oral anticoagulants (DOACs) are preferred for stroke prevention in atrial
fibrillation (AF). However, off-label doses have been associated with increased risk of …

Aims To describe the prevalence and associated factors of inappropriate doses of direct oral
anticoagulants (DOAC) in a national registry of patients of real clinical practice. Methods and …

Abstract Background and Objectives Atrial fibrillation (AF) and the associated risk of stroke
are emerging epidemics throughout the world. Suboptimal use of oral anticoagulants for …

Background Inappropriate dosing of direct oral anticoagulants (DOACs) has been
associated with clinical safety and efficacy; however, little is known about clinical data …

Background We evaluated adherence to dosing criteria for patients with atrial fibrillation (AF)
taking dabigatran or rivaroxaban and the impact of off-label dosing on thromboembolic and …

Background: The use of direct oral anticoagulant (DOAC) off-label doses in atrial fibrillation
(AF) patients may result in poor clinical outcomes. However, the true prevalence remains …